A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
BioSpace | The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
While we’ve made some progress, unfortunately, it appears we still have work to do.
PINC AI™ is narrowing the gaps in maternal and infant care through standardized and timely data.
By automating AP processes, health system leaders can jumpstart their organizations’ rebound from the pandemic and embark on a path to improved solvency and profitability.
Initiative builds on Premier and its members’ efforts to help ensure a more agile, transparent and robust U.S. healthcare supply chain
One database offers visibility into the maternal and infant relationship to support clinical research and medical solution development that can impact perinatal health.
Remitra™ is helping healthcare AP teams save time, reduce errors and fraud, and free resources to work on projects that drive business forward.
Premier responds to CMS' proposed policies on the CY 2023 payment update, 340B, N95s and CDS.
FDA Public Workshop | Premier’s Soumi Saha was invited to participate in the workshop’s June 7 panel discussion: "Resilience Defined and Measured."
Innovation in data analytics and real-world evidence is helping life sciences companies expedite treatment development and uncover new uses for existing treatments.
Premier applauds CMS for addressing several aspects of the Medicare Shared Savings Program (MSSP).
Remitra™ partnered with HFMA to dig into how AP automation can help healthcare finance leaders reduce costs and optimize spend.